Sarah Gheuens
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Dr. Sarah Gheuens is a Chief Medical Officer, Head-Research & Development at Agios Pharmaceuticals, Inc. She is on the Board of Directors at Viridian Therapeutics, Inc. Dr. Gheuens was previously employed as an Executive Medical Director by Biogen, Inc. She received her graduate degree from Harvard Medical School, a doctorate degree from the University of Antwerp and a doctorate degree from Vrije Universiteit Brussel.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2026 | 80 277 ( 0,13% ) | 2 M $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Directeur Technique/Scientifique/R&D | 01/12/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Vrije Universiteit Brussel
Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national